PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Pregabalin - Migraine (prevention)
PAD Profile : Pregabalin - Migraine (prevention)
Keywords :
migraine prophylaxis, antimigraine, migraine prevention
Brand Names Include :
Alzain
Axalid
Lyrica
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Botulinum toxin type A
- Flunarizine dihydrochloride
- Pizotifen malate
- Erenumab
- Galcanezumab
- Fremanezumab
- Propranolol hydrochloride
- Topiramate
- Amitriptyline hydrochloride
- Gabapentin
- Rimegepant
- Candesartan cilexetil
- Clonidine hydrochloride
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
07 July 2021
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System (ICS) Area Prescribing Committee has agreed a NON-FORMULARY traffic light status for pregabalin, based on the fact that pregabalin has the same mode of action as gabapentin which is not recommended by NICE (CG150), to be offered to patients for the prophylactic treatment of migraine.
Follow link to NICE CG150 here: https://www.nice.org.uk/guidance/cg150
Associated BNF Codes
04. Central Nervous System
04.07.04. Antimigraine drugs